Provided by Tiger Trade Technology Pte. Ltd.

Guardant Health Inc.

161.50
-7.0200-4.17%
Post-market: 160.68-0.8229-0.51%19:51 EDT
Volume:1.82M
Turnover:296.64M
Market Cap:21.67B
PE:-46.09
High:169.60
Open:166.35
Low:160.23
Close:168.52
52wk High:176.58
52wk Low:53.40
Shares:134.20M
Float Shares:129.78M
Volume Ratio:1.03
T/O Rate:1.40%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.5037
EPS(LYR):-3.3203
ROE:-4584.47%
ROA:-18.07%
PB:-97.24
PE(LYR):-48.64

Loading ...

Guardant Health director Myrtle S. Potter disposes of 1,556 common shares worth $204,084.96

Reuters
·
Jun 24

Hikma joins Guardant Health as platinum sponsor at UAE International Oncology Forum IOF 2026

Reuters
·
Jun 22

Guardant Health shareholders elect directors at annual meeting

Reuters
·
Jun 19

Living Longer Is Big Business. These Stocks Will Benefit. -- Barrons.com

Dow Jones
·
Jun 19

What GH Research (GHRS)'s Phase 2a Postpartum Depression Breakthrough Means For Shareholders

Simply Wall St.
·
Jun 18

Analysts Offer Insights on Healthcare Companies: IQVIA Holdings (IQV), BridgeBio Pharma (BBIO) and Guardant Health (GH)

TIPRANKS
·
Jun 17

U.S. RESEARCH ROUNDUP-CF Industries, Kimberly-Clark, Welltower

Reuters
·
Jun 17

Guardant Health Inc : Jefferies Raises Target Price to $150 From $130

THOMSON REUTERS
·
Jun 17

Guardant Health director Tariq Musa disposes of 116 common shares for $15,102.04

Reuters
·
Jun 17

Guardant Health CIO Kumud Kalia sells 3,418 shares worth $445,156.57

Reuters
·
Jun 16

Crinetics Presents Full Results From Phase 2 Trial of Atumelnant in Congenital Adrenal Hyperplasia (CAH) in Oral Presentation at ENDO 2026

GlobeNewswire
·
Jun 15

Crinetics Presents Long Term Data at ENDO 2026 Confirming PALSONIFY™ (paltusotine) Provides Durable, Consistent Acromegaly Control

GlobeNewswire
·
Jun 15

Guardant Health CIO Kumud Kalia sells 5,000 common shares worth $652,030.00

Reuters
·
Jun 13

Guardant Health Set to Benefit From Genomic Profiling Growth, RBC Says

MT Newswires Live
·
Jun 12

RBC Initiates Guardant Health at Outperform With $185 Price Target

MT Newswires Live
·
Jun 12

U.S. RESEARCH ROUNDUP- Adobe, Caseys General Stores, Oracle

Reuters
·
Jun 12

Guardant Health Inc : RBC Initiates Coverage With Outperform Rating; Target Price $185

THOMSON REUTERS
·
Jun 12

BUZZ-U.S. STOCKS ON THE MOVE-Enliven Therapeutics, DXC Technology, Humacyte

Reuters
·
Jun 11

Guardant Health Says FDA Approved Guardant360 CDx as Companion Diagnostic for Non-Small Cell Lung Cancer Therapy

MT Newswires Live
·
Jun 11

BUZZ-Guardant Health rises as FDA clears blood test for lung cancer drug use

Reuters
·
Jun 11